GI & Hepatology JC068: Abdominal Distension: Ascites And Cirrhosis Flashcards

1
Q

Complications of Cirrhosis

A
  1. Ascites
  2. Spontaneous Bacterial Peritonitis (SBP)
  3. Hepatorenal syndrome (HRS)
  4. Variceal bleeding
  5. Hepatic Encephalopathy (late stage)
  6. HCC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

***Pathogenesis of Complications

A

Cirrhosis
—> Portal hypertension
—> Splanchnic arterial vasodilation
—> ↓ Total systemic vascular resistance
—> Arterial underfilling
—> ↓ Effective arterial blood volume / BP
—> Stimulation of neurohormonal systems (
RAAS, SNS, ***AVP (arginine vasopressin, same as vasopressin / ADH))

↑ RAAS / SNS:
↑ Renal tubular reabsorption of Na
—> ***Na retention
—> Ascites + Edema

AVP:
↑ Water reabsorption in distal renal tubules
—> **Water retention
—> **
Dilutional hyponatraemia

↑↑ RAAS / SNS:
↓ Systemic / Local vasodilators +/- ↑ Local vasoconstrictors
—> ***Renal vasoconstriction
—> Perfusion of kidney jeopardised
—> Hepatorenal syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ascitic fluid

A

Physical properties:
1. Colour
- straw (normal, pale yellow)
- blood-stained (∵ traumatic tapping, if severe need to suspect rupture viscera)
- chylous (lymphoma, TB)

  1. ***Protein
    - may be as high as 40 g/L without special clinical significance
  2. ***Rate of reabsorption (of fluid back into systemic circulation)
    - 900ml/day (in tense ascites, may ↑ to 1.5 L/day)
  3. WCC (helpful to diagnose SBP)
    - <500 (
    <250 PMN)
  4. Malignant cells
    - <10% positive in malignant ascites (very low yield)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Investigations of Ascites

A
  1. ***Diagnostic paracentesis for WBC in every patient
    - ∵ need to rule out SBP
  2. Glucose level (not useful), Malignant cells (low yield)
  3. Serum-ascites albumin gradient (SAAG)
    - **
    Serum albumin - Ascitic fluid albumin
    - normal <11, elevated in abnormal situations (more free fluid leaving circulation ∵ ↑ hydrostatic pressure —> concentrating serum albumin)
    - >11 g/L (
    ↑ Hydrostatic pressure) —> Portal hypertension
    - <11 g/L (NO portal hypertension) —> need to consider other causes of ascites
    —> **
    ↑ Capillary permeability: e.g. malignancy, TB peritonitis, pancreatitis
    —> ***↓ Oncotic pressure: e.g. nephrotic syndrome (although protein not move across to interstitial space —> protein in serum is already low in the beginning —> ∴ SAAG is still low)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of Ascites

A
  1. Bed rest (for in-hospital patients)
    - ∵ better perfusion, better renal perfusion
  2. ***Salt restriction
    - 0.5-2 g/day
  3. ***Fluid restriction
    - 0.8-1 L/day

—> Effective for mild ascites
—> Difficult patient compliance

  1. ***Diuretics
  2. ***Therapeutic paracentesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diuretics

A

Aim at ***1kg weight loss / day

  1. Distal loop diuretics
    - advantage: K sparing
    - **Spironolactone (Aldactone A)
    —> most physiological agent (∵ hyperaldosteronism in cirrhosis)
    —> high incidence of painful gynaecomastia esp. in alcoholic cirrhosis
    —> relative CI in male
    - **
    Amiloride, Triamterine
  2. Proximal loop diuretic
    - to be added on if insufficient
    - ***Bumetanide (Loop diuretic)
    - Furosemide (absorption in GI tract unreliable in portal hypertension)
  3. **IV diuretics + **Albumin infusion (to ↑ oncotic pressure in IV volume)
    - oral diuretic may not have satisfactory response ∵ poor absorption in GI tract due to edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Therapeutic paracentesis

A
  • for ***tense ascites
  • reserved for symptomatic relief only
  • avoid draining too rapidly / large volume
  • complications
    —> **shock
    —> **
    electrolyte disturbance
    —> ***renal impairment
    —> infection
    —> encephalopathy

Abdominal tap of **4-6L is safe
- with **
albumin infusion (to top up oncotic pressure) +/- if patient has peripheral edema (more buffer to ***shift fluid into IV volume (rather than lose in tap))
—> can prevent IV volume depletion

Complications:
- bleeding from puncture site
- **sepsis
- **
perforation of caecum with R-sided puncture (∵ caecum a fixed organ) (recommend in ***L-sided lower abdomen instead, sigmoid mesentery will make sigmoid float away)
(- shock
- electrolyte disturbance
- uraemia
- encephalopathy
- protein deletion (SpC Medicine))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Spontaneous Bacterial Peritonitis (SBP)

A

Other 2 forms of inflammation of peritoneal fluid:
1. Monomicrobial bacterascites (有細菌, 無PMN)
- **positive for a single organism in ascitic fluid —> antibiotics still indicated
- but **
no ↑ PMN (<250)
- a ***mild form of infected ascites

  1. Culture negative neutrocytic ascites (CNNA) (無細菌, 有PMN)
    - opposite to above
    - **cannot identify bacteria —> **NO antibiotics indicated, only observe
    - **PMN >=250 / 500 (i.e. system can mount inflammatory response to get rid of bacteria)
    - no alternative cause of ↑ in PMN
    - almost certainly an **
    early form of SBP

Pathogenesis:
**Deficient serum complement activity / **Poor endothelial system function / GI haemorrhage / Invasive procedures
—> Bacteraemia
—> **Monomicrobial bacterascites
1. —> Good ascitic fluid opsonic activity —> resolution by macrophages
2. —> Intermediate ascitic fluid opsonic activity —> **
CNNA —> resolution
3. —> Poor ascitic fluid opsonic activity —> ***SBP

Clinical features (SpC Medicine):
1. **Asymptomatic
2. **
PUO
3. Encephalopathy
4. ***Abdominal S/S (none to marked)
5. Diarrhoea
6. Hypothermia
7. May be fatal / recurrent

Risk factors (UpToDate):
1. Advanced cirrhosis
2. Ascitic fluid total protein concentration <1 g/dL (<10 g/L)
3. Prior episode of SBP
4. Serum total bilirubin concentration >2.5 mg/dL
5. Variceal hemorrhage
6. Possibly malnutrition
7. Use of proton pump inhibitors

Complications:
1. Hepatorenal syndrome
2. ***Liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of SBP

A
  1. WCC
    - >500 WBC: suspicious
    - **>250 PMN in patients with S/S of SBP (e.g. **fever, ***abdominal pain) (more definite diagnosis)
    - >500 PMN in asymptomatic patients
    (vs CAPD peritonitis: >100 WBC / mm3)
  2. Culture
    - usually **Gram -ve / **Streptococci
    - may be ***negative
  3. pH (SpC Medicine)
    - pH <7.3 suspicious (if blood pH not acidotic)
    - pH <7.15 poor prognosis
    - Arterial-ascitic fluid pH gradient of 0.1 (normal: 0.02-0.05)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment of SBP

A

**Broad spectrum antibiotics
- **
3rd gen Cephalosporin (SpC Medicine)
- exponential ↓ in PMN count after initiation
- duration of treatment: **~5 days, can stop antibiotics as soon as PMN **<=250

Prevention of Recurrence of SBP:
**Quinolones (Norfloxacin): Long-term **selective intestinal decontamination
- incompletely absorbed by gut
- highly active against **gram -ve bacilli
- **
low activity against anaerobes (∵ do not want to wipe out flora)
- rarely causes bacterial resistance
- low SE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Renal failure in Liver diseases

A

Causes:
1. **Hepatorenal syndrome (∵ Renal vasoconstriction)
2. **
Hypovolaemia (Diuretics, GI bleeding) —> IV Fluid depletion —> Renal impairment
3. Sepsis
4. Nephrotoxic drugs
5. Parenchymal renal disease

Rmb:
- Renal impairment in cirrhosis / ascites —> first DDx is NOT Hepatorenal syndrome, instead ***Overdiuresis most common
- consider 2-5 before 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hepatorenal syndrome

A

Renal failure that occurs in patients with severe liver disease
- in absence of any pathological causes for development of renal failure

Pathogenesis:
↑↑ RAAS / SNS
—> ↓ Systemic / Local vasodilators +/- ↑ Local vasoconstrictors
—> ***Renal vasoconstriction
—> Perfusion of kidney jeopardised
—> Hepatorenal syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

***Diagnostic criteria of Hepatorenal syndrome

A
  1. Urine volume <500 ml/day (***Oliguria)
  2. ***Urine Na <10
  3. Urine osmolality (i.e. ***concentrated urine) > Plasma osmolality
  4. ***Absence of Haematuria
  5. ***Serum Na <130 (Dilutional hypoNa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of Hepatorenal syndrome

A
  1. Optimise BP
    - **Terlipressin/Glypressin +/- **Albumin

Terlipressin:
- vasoconstrictors (**↑ systemic vascular resistance, ↑ mean arterial pressure)
—> suppresses activation of SNS
—> improves central blood volume (?)
—> **
improves BP + renal perfusion pressure
—> ***↑ GFR + ↓ serum creatinine

Albumin:
- ↑ oncotic pressure —> ***↑ blood volume —> ↑ renal perfusion

Other drugs:
- Norepinephrine
- Octreotide

  1. Optimisation of renal haemodynamics
    - ***Paracentesis
    —> drainage of tense ascites (intraabdominal pressure physically pressing on renal system) may temporarily improve renal haemodynamics + renal function
    —> but may be associated with modest fall in BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Possible causes of bleeding in cirrhotic patients

A
  1. ***Varices (esophageal, gastric)
  2. Portal hypertensive gastropathy (SpC Medicine)
  3. Peptic ulceration
  4. ***Coagulopathy (generalised bleeding tendency) (∵ ↓ clotting factor synthesis + ↓ Plt due to splenomegaly)
  5. Others e.g. ***Mallory-Weiss syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Variceal bleeding

A
  • comes in column around lower end of esophagus
  • extend from ***EG junction up to lower esophagus

When does variceal bleeding occur?
Probably associated with vessel wall-stress
1. **Portal BP (unlikely to bleed if portal pressure **<12 mmHg (but hard to measure))
—> if high portal pressure
—> wall becomes thinner
—> rupture
2. Large vessels with ***thin walls

17
Q

***Management of Variceal bleeding

A

Management of cirrhotic patients with GI bleeding
1. **Shock treatment (fluid resuscitation, blood transfusion)
2. Monitor vital signs (Q1H)
3. **
Endoscopic diagnosis of source of bleeding (ulcer / variceal)
4. **Prevention / Treatment of HE (GI bleeding a precipitating factor for HE)
- **
Lactulose
5. **Correct coagulopathy: **Vit K1 therapy + Correction of clotting factor defects (in case there is any ***cholestatic elements —> ↓ Vit K absorption)

Management of Variceal bleeding:
Acute
1. Endoscopic treatment
- **Band ligation
- **
Sclerotherapy
- Variceal obliteration by tissue adhesive (for gastric varices in fundus)

  1. Drug therapy
    - Vasoconstrictors (Terlipressin, Octreotide)
    —> ↓ SMA, Splenic arterial flow —> ↓ Portal pressure
    —> ↓ Blood flow to gut
  2. Balloon tamponade
    - ***Sengstaken Blakemore tube
    - seldomly done
  3. Emergency surgery
    - ***transect esophagus
    - seldomly done

Long-term / Prophylaxis
1. **Propranolol / other β blockers (e.g. Nadolol, Carvedilol (SpC Medicine))
- Propranolol (TDS) vs Carvedilol, Nadolol (OD (preferred))
- **
↓ CO —> ↓ portal blood flow
- effective in prevention of rebleeding
- can be combined with vasodilators e.g. Isosorbide mononitrate
- should be stopped in end-stage cirrhosis (decreased CO may cause hypotension + hepatorenal syndrome), sepsis (SpC Medicine)
- target HR: ***50-60 (SpC Medicine)

  1. Repeated band ligation
    - better than long-term sclerotherapy
  2. ***Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Ultimate effect of treatment on patient survival
1. Liver transplantation

18
Q

Revision: Liver failure and Coagulopathy

A
  1. ***↓ Hepatic synthetic function —> ↓ clotting factors, inhibitors
  2. ***Thrombocytopenia (∵ Portal hypertension —> increased splenic sequestration i.e. hypersplenism)
  3. ***Cholestasis —> ↓ Vit K absorption —> ↓ active Vit K dependent factor + inhibitors
  4. Acquired dysfibrinogenaemia
  5. Failure to clear activated intermediates of coagulation and fibrinolysis from bloodstream
19
Q

Band ligation / Injection sclerotherapy

A
  • Immediately done (effective but can be difficult)
  • Need to ensure all remaining vessels should be sclerosed in the weeks after stopping of haemorrhage
  • Generally band ligation > injection sclerotherapy (create another puncture in varices)

Complications (few):
- **transient esophageal pain
- esophageal ulcers (rarely bleed)
- **
sloughing of bands during subsequent endoscopies (delay 7-10 days before next endoscopy (SpC Medicine))
- ***stricture (balloon dilatation to treat)
- mediastinitis (only for injection sclerotherapy)
- aspiration pneumonia

Disadvantage:
- cannot reach **gastric varices —> need **tissue adhesive
- stops acute bleeding in 80-90% but bleeding may recur in next few days —> overall success 60-70%

20
Q

Octreotide / Somatostatin

A
  • synthesised Octapeptide sharing 4 a.a. with Somatostatin —> longer t1/2, greater potency
  • action not well-defined
    —> **↓ Splanchnic blood flow in normal subjects
    —> **
    Data in cirrhosis contradictory with variable effects on portal, variceal pressure

Advantages:
- very minimal SE

Disadvantages:
- efficacy 60-70%
- now out of favour (∵ not as good as Terlipressin)

21
Q

Sengstaken-Blakemore tube

A
  • requires careful handling
  • need to connect tube to bedside for traction (扯住條tube) otherwise tube fall into stomach

Gastric balloon: anchor tube in place
Esophageal balloon: compress varices (tamponade effect)

Disadvantages:
- patient discomfort
- **esophageal ulceration / necrosis (keep in place <24 hours (SpC Medicine))
- **
asphyxia due to balloons (obstruct airway)
- ***aspiration pneumonia

22
Q

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

A
  • stenting between hepatic vein and portal vein
  • portal vein —> shunt directly bypass liver sinusoids —> hepatic vein
  • ***↓ portal pressure

Indications:
1. **Variceal bleeding
- resistant + recurrent
- acute uncontrolled
2. **
Refractory ascites
3. Refractory cirrhotic hydrothorax
4. Budd-Chiari syndrome
5. Prophylactic portal decompression prior to transplant

Contraindications:
1. **RH failure (∵ ↑ venous return)
2. **
Frequent HE
3. ***HCC
4. Liver abscess / cholangitis
5. DIC
6. Cavernous formation of portal vein
7. Thrombosis of R/L IJV, SVC / IVC

Acute complications:
1. Procedure-related
- Severe / fatal **intra-abdominal bleeding from perforation of liver capsule / stent at portal bifurcation
- Haemobilia
- Haematoma of liver
2. **
Thromboembolism with clot in stent
3. ***Volume overload with heart failure
4. Renal failure (related to dye)
5. DIC
6. Sepsis

Chronic complications:
1. ***HE
2. Stent stenosis / occlusion
3. Recurrent bleeding (∵ non-portal hypertensive bleed / inadequate portal decompression (SpC Medicine))

23
Q

Portal hypertensive gastropathy (SpC Medicine)

A

Congestive gastropathy:
- Portal hypertension causing mucosal vascular ectasia (NOT due to H. pylori)
- Occurrence common
- More frequent in patients with large varices, poor liver function
- ?↑ by sclerotherapy which ↑ gastric mucosal congestion
- Mostly causes occult bleeding

Treatment:
- Beta-blockers

Related condition (Wiki):
Gastric antral vascular ectasia (GAVE) / Watermelon stomach
- However, in GAVE, the ectatic blood vessels are more commonly found in the antrum or lower part of the stomach